Cibc World Markets Corp Has $2.57 Million Position in Zimmer Biomet Holdings, Inc. (ZBH)

Cibc World Markets Corp boosted its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 52.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,007 shares of the medical equipment provider’s stock after buying an additional 7,269 shares during the period. Cibc World Markets Corp’s holdings in Zimmer Biomet Holdings were worth $2,565,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Parkside Financial Bank & Trust raised its stake in shares of Zimmer Biomet Holdings by 2.7% in the first quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock worth $102,000 after buying an additional 22 shares in the last quarter. Independent Advisor Alliance bought a new stake in shares of Zimmer Biomet Holdings during the fourth quarter worth approximately $103,000. Capital Guardian Trust Co. raised its stake in shares of Zimmer Biomet Holdings by 52.1% in the fourth quarter. Capital Guardian Trust Co. now owns 1,229 shares of the medical equipment provider’s stock worth $127,000 after buying an additional 421 shares in the last quarter. Sandy Spring Bank raised its stake in shares of Zimmer Biomet Holdings by 1.7% in the first quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock worth $149,000 after buying an additional 20 shares in the last quarter. Finally, Ledyard National Bank raised its stake in shares of Zimmer Biomet Holdings by 9.3% in the first quarter. Ledyard National Bank now owns 1,293 shares of the medical equipment provider’s stock worth $157,000 after buying an additional 110 shares in the last quarter. 84.34% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Zimmer Biomet Holdings, Inc. (NYSE ZBH) opened at 127.45 on Tuesday. The firm’s 50-day moving average price is $121.18 and its 200 day moving average price is $116.48. The company has a market capitalization of $25.70 billion, a price-to-earnings ratio of 52.17 and a beta of 1.23. Zimmer Biomet Holdings, Inc. has a one year low of $95.63 and a one year high of $133.21.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its earnings results on Thursday, April 27th. The medical equipment provider reported $2.13 EPS for the quarter, topping analysts’ consensus estimates of $2.11 by $0.02. Zimmer Biomet Holdings had a net margin of 6.36% and a return on equity of 16.80%. The business had revenue of $1.98 billion during the quarter, compared to the consensus estimate of $1.96 billion. During the same quarter in the previous year, the firm posted $2.00 EPS. The firm’s revenue was up 3.8% on a year-over-year basis. On average, equities research analysts expect that Zimmer Biomet Holdings, Inc. will post $8.54 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Shareholders of record on Friday, June 23rd will be given a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 0.76%. The ex-dividend date of this dividend is Wednesday, June 21st. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is presently 39.67%.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another site, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/2655149/cibc-world-markets-corp-has-2-57-million-position-in-zimmer-biomet-holdings-inc-zbh.html.

ZBH has been the subject of a number of recent research reports. Canaccord Genuity reissued a “buy” rating on shares of Zimmer Biomet Holdings in a report on Friday, April 28th. Oppenheimer Holdings, Inc. set a $132.00 price objective on Zimmer Biomet Holdings and gave the stock a “buy” rating in a report on Friday, April 28th. Royal Bank Of Canada reissued a “buy” rating and set a $133.00 price objective on shares of Zimmer Biomet Holdings in a report on Tuesday, March 14th. ValuEngine lowered Zimmer Biomet Holdings from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Finally, Wells Fargo & Co lowered Zimmer Biomet Holdings from an “outperform” rating to a “market perform” rating in a report on Friday, April 28th. Two research analysts have rated the stock with a sell rating, four have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $135.88.

In other Zimmer Biomet Holdings news, VP Chad F. Phipps sold 6,200 shares of Zimmer Biomet Holdings stock in a transaction that occurred on Friday, May 5th. The shares were sold at an average price of $116.76, for a total value of $723,912.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sang Yi sold 17,731 shares of Zimmer Biomet Holdings stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $124.56, for a total transaction of $2,208,573.36. The disclosure for this sale can be found here. In the last ninety days, insiders sold 111,262 shares of company stock valued at $13,103,927. 1.07% of the stock is currently owned by insiders.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
President Trump Hurting Tourism in the U.S.
President Trump Hurting Tourism in the U.S.
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Blue Apron Filed Thursday for Public Offering
Blue Apron Filed Thursday for Public Offering
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Large Auto Lender Checked Just 8% of Incomes for Applicants
Large Auto Lender Checked Just 8% of Incomes for Applicants


Leave a Reply

© 2006-2017 Ticker Report. Google+.